Clinical trials: The bridge to an optimal registration
Van derden29/10/19
Find the gaps together with us at the ProPharma Group Centre of Excellence; a life cycle approach
Will your clinical development in the future deliver new treatment options? Solid science will always be a foundation, but a successful development process stretches beyond scientific opportunities. Find the gaps and apply a life cycle approach for product development.
Professor Doctor Annemieke Aartsma-Rus will inform you on the lessons learned from a failure of a registration trial on a Duchenne muscular dystrophy treatment.
Step into the world of Phase II studies based on a multidisciplinary approach and strategy building. Discuss topics as dose finding, comparator picking, epidemiology, and dosing formulations. Focus on small (Phase II/III) studies on rare diseases.
Program
- 16.30 Doors open
- 17.00 Welcome
- 17.15 – 18.15 Annemieke Aartsma-Rus (Professor of translational genetics, LUMC), Therapy development for rare diseases takes more than a therapeutic compound
- 18.15 – 19.00 Thomas de Vlaam (Founder and CEO, Amylon Therapeutics): Industry perspective
- 19.00 – 19.30 ProPharma Group: Regulatory affairs
- 19.30 Drinks & Networking
- 20.30 Close
Register for free at reception@xendo.com
